TABLE 1.
Site | Na | K13 candidate artemisinin resistance markers |
Increased copy number |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
PfK13 A675V |
PfK13 C469Y |
|||||||||
Wild type (%) | Mixed (%) | Mutant (%) | Wild type (%) | Mixed (%) | Mutant (%) | N | pfmdr1 (%) | plasmepsin2 (%) | ||
Agago | 42 | 40 (95.2) | 1 (2.4) | 1 (2.4) | 40 (95.2) | 1 (2.4) | 1 (2.4) | 30 | 2 (6.7) | 1 (3.3) |
Amolatar | 48 | 48 (100) | 0 | 0 | 48 (100) | 0 | 0 | 41 | 0 | 0 |
Arua | 43 | 42 (97.7) | 0 | 1 (2.3) | 43 (100) | 0 | 0 | 37 | 0 | 0 |
Jinja | 48 | 48 (100) | 0 | 0 | 48 (100) | 0 | 0 | 37 | 0 | 1 (2.7) |
Kanungu | 48 | 48 (100) | 0 | 0 | 48 (100) | 0 | 0 | 45 | 0 | 0 |
Kole | 47 | 46 (97.9) | 0 | 1 (2.1) | 46 (97.9) | 0 | 1 (2.1) | 31 | 0 | 0 |
Lamwo | 43 | 39 (90.7) | 0 | 4 (9.3) | 41 (95.4) | 1 (2.3) | 1 (2.3) | 35 | 0 | 0 |
Mubende | 45 | 45 (100) | 0 | 0 | 44 (97.8) | 1 (2.2) | 0 | 39 | 0 | 0 |
Tororo | 48 | 48 (100) | 0 | 0 | 48 (100) | 0 | 0 | 40 | 0 | 0 |
N, number of samples successfully evaluated.